Clorox Company (CLX) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Clorox Company (CLX)

96.56

+3.49 (3.75%)

as of Jul 10, 2026, 8:00:00 pm Market Open.

76 watching

Investor Insights

Jul 11, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

Clorox Company, symbol CLX-N, is a dividend aristocrat that has faced various challenges in recent years, including a notable -11.83% decline this year and a 30% drop since the beginning of the year. The company's 5% dividend yield is a positive aspect, as it has a history of increasing dividends for 24 consecutive years, reflecting its commitment to shareholder returns. Analysts note its current trading at 17x PE, which is lower than historical valuations of 18-20x, suggesting potential upside. The normalization of supply chains and return to pre-war pricing in petrochemicals is encouraging, yet concerns over inflation and consumer preferences may impact their sales. The company’s earnings are finally finding a consistent upward trajectory, with expected growth of 6-8%, but its reliance on oil prices adds uncertainty amid geopolitical tensions.

Consensus

mixed

Valuation

undervalued

Similar

Procter&Gamble,PG

COMMENT

A big winner last year for obvious reasons, nut it's been selling off the past 9 months as the reopening approaches and as the company faces tough comps. Today, they delivered a mixed quarter of a topline miss and bottom line beat, and management adjusted down their full-year earnings forecast. It's $5 from its 52-week low. Has this fully de-risked? Does it face rising costs?

DON'T BUY

Wall Street is circumspect about it, considering it a stay at home stock. As a battleground stocks now, avoid.

TOP PICK

It has been around since 1913. They ran higher as the pandemic was getting under swing. They sold off because the spike in demand will decline as the pandemic goes away. He is not convinced demand will decline. People are more mindful now of germs and washing their hands. Most of their sales come from brands that are number 1 or 2. They have little or no debt. (Analysts’ price target is $213.47)

Premium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK

Stockchase Research Editor: Michael O'Reilly CLX rose to to the forefront at the beginning of the pandemic with its sterile cleaning products. Now with the economy beginning to reopen, demand for its products are expected to remain strong. Margins continue to expand for the 9th consecutive period thanks to volume and cost-saving efficiencies. It pays a good dividend, that has been increasing for 40 consecutive years and is backed by a 45% payout ratio. We would buy this with a stop-loss at $150 looking to achieve $220 -- upside potential over 17%. Yield 2.34% (Analysts’ price target is $219.29)

WAIT

They just delivered 26% organic growth, but they won't meet demand for wipes until the end of the year. What happens to this stock when we return to normal? Will hygiene habits endure? Will demand still be there? He really doesn't know yet. Maybe they can still sell a lot of wipes, but it may not be enough to move the needle.

BUY

It reported today a massive 90-cent earnings beat, and the stock popped up more than 4%. He recommends this as part of the Hygiene Bull Market during Covid.

BUY

It has thrived during Covid which offers a range of cleaning products. This stock will do regardless of who wins the White House.

BUY

This is synonymous with lockdowns, but still fell 2% in today's big sell-off. Hygiene stocks will continue to see a bull run during this pandemic.

DON'T BUY

The rally has been played out, despite the current "hygiene" rally driven by Covid. Clorox owns a range of products outside hygiene. A mish mash.

DON'T BUY

He doesn't mind it and has owned it, but current levels are too high. There are better stocks elsewhere.

DON'T BUY

He is not a huge fan. It has always been an expensive place to park money. You pay a high premium for low growth. There is not a lot of room to grow in traditional product lines. Growth will be challenged for a year or so.

BUY

A very good company. It's one of the consumer product stocks that has actually had constant growth. They generate free cash flow. Dividend growth has been above average.

COMMENT

This is in the Consumer Products/Consumer Staples category, which he is more negative on. However, this has done better than the group. They recently produced a decent earnings number. Prefers other areas.

COMMENT

Their biggest problem is that it is in “consumer staples”, a sector that is very expensive. These companies have very little scope for growth. There was expensive premiumization on a lot of these companies and not in a position to trade down as people wanted less expensive products. There was also a lot of reliance on growth in emerging markets, which has decelerated very sharply.

COMMENT

This is a part of the whole consumers package goods business that is under incredible pressure from commoditization. The stock has done very, very well. It had high PEs just because of the quality of their cash flow and that their brand names are recognized. Now that we are getting into higher interest rates, that is going to start to get squeezed. Maybe the weakening of the US$ will allow some foreign profits to come through a little better, but generally the group is under a lot of pressure from generics, etc. If you own it, you are not going to lose a lot of money.

Showing 16 to 30 of 36 entries

Most Recent Experts

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Kevin Simpson

Capital Wealth Planning

Bill Baruch, Founder, Blue Line Capital

Blue Line Capital

Darren Sissons

Campbell Lee & Ross

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Clorox Company (CLX)